[1] Avery AJ, Anderson C, Bond CM, et al.Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys[J].Health Technol Assess, 2011, 15(20):231-234. [2] Jha N, Shankar PR, Bajracharya O, et al. Adverse drug reaction reporting in a pharmacovigilance centre of Nepal[J]. Australas Med J, 2012, 5(5):268-271. [3] Wei JX, Li M, Sun YH, et al. A novel method for signal detection of adverse drug reactions based on proportional reporting ratios[J]. Pharm World Sci, 2010, 32(5):658-662. [4] 国家卫生部.《处方常用药品通用名目录》[M].长沙:湖南科技出版社, 2007-7-1. [5] 国家药品不良反应监测中心暨国家食品药品监督管理局药品评价中心. WHO药品不良反应术语集[M].2002. [6] WHO世界卫生组织.国际疾病分类(international Classification of diseases , ICD-10)[S] . [7] Hawcutt DB, Mainie P, Riordan A, et al. Reported paediatric adverse drug reactions in the UK 2000-2009[J]. Br J Clin Pharmacol, 2012, 73(3):437-446. [8] Hauben M, Zhou XF.Quantitative methods in pharmacovigilance:focus on signaldetection[J].Drug Saf, 2003, 26(3):159. [9] Egberts AC, Meyboom RH, Van Puijenbroek EP. Use of measures of disproportionality in pharmacovigilance: three Dutch examples[J]. Drug Saf, 2002, 25(6):453. [10] Evans SJW, Waller PC, Davis S. Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports[J].Pharmacoepidemiol Drug Saf, 2001, 10(6):483-486. [11]Bate A, Edwards IR.Data mining in spontaneous reports[J].Basic Clin Pharmacol Toxicol, 2006, 98(3):324-330. [12]Van Puijenbroek EP, Bate A, Leufkens HG, et al.A comparison of measures of disproportionality for signal detection in spontaneous reporting systems for adverse drug reactions[J]. Pharmacoepidemiol Drug Saf, 2002 , 11(1):3-10. [13]Kubota K, Koide D, Hirai T. Comparison of data mining methodologies using Japanese spontaneous reports[J]. Pharmacoep- idemiol Drug Saf, 2004, 13(6): 387-394. [14]In Young Choi, Tae-Min Kim. Perspectives on Clinical Informatics:Integrating Large-Scale Clinical, Genomic and Health Information for Clinical Care[J].Genomics Inform , 2013, 11(4):186-190. |